lab metric
Non-HDL Cholesterol
Table of contents
Description
Non-HDL cholesterol is calculated as Total Cholesterol − HDL Cholesterol. It represents the cholesterol carried by all potentially atherogenic particles (including LDL and triglyceride-rich remnants). In many real-world cases, non-HDL tracks cardiovascular risk better than LDL-C alone—especially when triglycerides are elevated.
Why it matters
Non-HDL is a practical “all-in” marker of atherogenic cholesterol burden. It’s easy to calculate from a standard lipid panel and remains useful even in non-fasting states. Many clinicians use it as a secondary target—particularly when insulin resistance or high triglycerides are present.
Interpreting the number (general)
Lower is generally better. Targets vary by guideline and risk level, but non-HDL goals are often set about 30 mg/dL higher than the LDL-C goal for the same risk category.
What drives non-HDL higher
Genetics, diet patterns high in saturated fat, excess weight, insulin resistance, diabetes, and hypothyroidism can all contribute. Lipid-lowering therapy (statins, ezetimibe, PCSK9s) and lifestyle changes that improve insulin sensitivity can reduce non-HDL.
Educational only, not medical advice. For a clearer risk picture, interpret non-HDL alongside ApoB, Lp(a), blood pressure, and glucose markers with a clinician.
Frequently Asked Questions
Clarity before
you commit
Answers on setup, scale, and support to remove blockers.
